País: Reino Unido
Língua: inglês
Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)
Nadolol; Bendroflumethiazide
Sanofi-Synthelabo Ltd
C07BA12
Nadolol; Bendroflumethiazide
40mg ; 5mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02040000